HSCT was an independent risk factor affecting only FSH values (OR 9.7, P = 0.003), even if it also showed a trend toward a greater risk of ovarian damage also in relation to AMH and AFC (OR 4.5 and 3.3; P = 0.109 and P = 0.115, respectively) (Supplementary Tables 1 and 2).
Evaluation of the entire cohort demonstrated that patients treated with IST > 0 and < 35 days showed a trend to improved overall survival (IST 0 vs. > 35 vs. < 35 was 533: 95%CI 446 - 620 vs. 448: 95%CI 361 - 535 vs. 1169: 95%CI 800 - 1538 days, p=0.109, log-rank test) (See Figure 3 and Table 2 ).
A model with Treatment, Age, and Sex as main effects showed a trend toward smaller infarcts with neutrophil depletion (β = − 8.0% hemisphere, p = 0.109), but this was not significant (model p = 0.096, R2 = 0.164).
Compared with the ADNI-1-matched cohort, subjects on ALZ-801 showed a trend to decreased atrophy at 52 weeks ( p = 0.109) that became statistically significant at 104 weeks ( p = 0.0014), as shown in Fig. 4 .
EV TF activity showed a trend toward correlating with D-dimer levels ( P = .109).
At day 28, the abaloparatide group showed a trend toward greater BV vs vehicle (multiplicity‐adjusted P = .109; Table 2 ).
This increase was statistically significant for non-IRIS controls (p = 0.031), while TB-IRIS patients showed a trend (p = 0.109).
Nevertheless, comparison between the preoperative impedance and the one measured after the 3rd stimulation week showed a trend towards increased values for the uncoated group (p = 0.109), while for the coated electrodes almost no difference was found (all p values >0.800).
Furthermore, CAR showed a trend towards significant associations with 8MWT (adjusted R 2 = .226, R 2 change = .174 F = 2.312, P = .109, β = .452, P = .064) and 6MWT (adjusted R 2 = .236, R 2 change = .182 F = 2.387, P = .101, β =−.472, P = .058).
CCI) back to SHAM levels and showed a trend towards restoration to SHAM levels with Tyr1325 (p = 0.1091; CCI + NYX-2925 vs.
As predicted, lmo2316 was significantly upregulated ( p = 0.0014) and lmo1119 showed a trend toward downregulation during intracellular growth ( p = 0.1091; Figure 5A ).
Results for CHR with improved disease burden showed a trend towards higher rates in the ropeginterferon arm vs control (55.1% vs 37.1%, respectively; RR: 1.49 [95% CI: 0.91 to 2.43], p = 0.1092 in patients < 60 years; 43.5% vs 36.1%; RR: 1.22 [95% CI: 0.70 to 2.11], p = 0.4774 in those ≥60 years; Fig. 1 B i ; Supplementary Digital Content, Table 7).
Non-selective NSAIDs showed a trend (HR 0.85, 95% CI 0.69 to 1.04, p=0.1094) without reaching statistical significance, and initiation timing, duration, or dose did not significantly affect PFS in this subgroup.
Additionally, L-Ac-SDKP treatment showed a trend to reduce the mRNA expression of Il6 ( p = 0.1094 vs.
However, TB co-infected individuals showed a trend toward higher rates of increase in CD4 cells compared to non-TB patients (9.55 cells/mm 3 versus 8.66 cells/mm 3 per month, p = 0.1097).
Breakfast-related changes in how much subjects wanted to eat over 6 h showed a trend for greater hunger suppression with increasing amounts of avocado intake ( p = 0.11).
The S-QoL total score correlated positively with the emotional contagion subscore ( r = 0.29, p < 0.05 corrected) and showed a trend with the affective subscore ( r = 0.26, p = 0.11 corrected).
The following polyphenols showed a trend for increase: quercetin (105%, P = 0.11) homovanillic acid (20%, P = 0.08) and p -coumaric acid (68%, P = 0.08).
Those who received the rifaximin showed a trend for decreased rates of recurrence of CDI (31% versus 15%, p = 0.11). 29 Adding the option of a rifaximin chaser provided the practicing clinician with another choice for those with multiply recurrent CDI.
In EVT, preeclampsia induced pronounced changes in cholesterol transporter expression: ABCG1 was significantly downregulated (95th percentile CPM: Ctrl = 335.2; PE = 146.0, p = 3.60e-07), while ABCA1 showed a trend toward upregulation (95th percentile CPM: Ctrl = 261.4; PE = 528.2, p = 0.11) ( Figure 3C ; Supplementary Figure S5 ). 3.4 Analysis of differentially expressed genes in BeWo b30 cells following hypoxia induction Hypoxia induction using the oxoquinoline derivative in BeWo b30 cells resulted in changes in the expression of 4,879 genes, of which 2,562 were upregulated and 2,317 were downregulated (see Figure 4 ).
For walking performance ( Dual-Task—Walk ), higher prefrontal ΔO 2 Hb cost showed a trend for an association with slowing of walking speed ( r = 0.28, p = 0.11; Figure 6A ), as well as with shorter stride length ( r = 0.33, p = 0.06; Figure 6B ).
Interestingly, the cap at the centre of the lesion (i.e., mid-lateral position) showed a trend for thinning as a result of increased age ( p = 0.11) in vehicle-treated animals ( Figure 3 F).
Analysis of mean muscle fiber type CSA showed a trend toward an increase in type II muscle fiber area in both groups ( p = 0.11, interaction p = 0.98), whereas type I muscle fiber CSA increased in the OC group ( n = 9, 3821 ± 197 to 4490 ± 313 mm 2 , p < 0.05), but not in NOC ( n = 7, 4020 ± 348 to 3777 ± 354 mm 2 , p = 0.40) (interaction p < 0.05).
Elevated lysine showed a trend toward statistical significance ( P =0.11) in the homozygous mutant and was statistically significant in the compound heterozygote [WT, 272.80±61.47 vs Cps1 0/N674I , 366.30±67.68 ( P =0.009 vs WT)].
This was reflected by the difference in volume at day 21 between the two groups which showed a trend (156.6 ± 83.6 mm 3 for infliximab compared to 310.0 ± 49.8 mm 3 for the control group, p = 0.11).